tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY

Compare Incyte (INCY) vs. Competitors

Compare
1,881 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$110.57
$20.94B
18.55
51.07%
9 Buy
9 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$61.31
$11.54B
22.97
-9.71%
14 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$46.19
$11.71B
19.45
35.02%
7 Buy
8 Hold
1 Sell
Moderate Buy
United Therapeutics
$503.69
$21.64B
19.09
39.01%
5 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$213.28
$12.79B
-50.22
55.35%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$33.90
$20.36B
14.28
52.84%
5 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
110.57
40.03
56.75%
BMRN
BioMarin Pharmaceutical
61.31
-6.07
-9.01%
EXEL
Exelixis
46.19
10.17
28.23%
UTHR
United Therapeutics
503.69
138.72
38.01%
ASND
Ascendis Pharma
213.28
84.09
65.09%
GMAB
Genmab
33.90
11.75
53.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts